Voyager Therapeutics Inc (VYGR) financials · rev $40.4M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Voyager Therapeutics Inc (VYGR) rev $40.4M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $40.4M | $80.0M |
| Operating Income | -$131.8M | -$83.3M |
| Net Income | -$119.7M | -$65.0M |
| EPS (Diluted) | -$2.04 | -$1.13 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $252.3M | $393.1M |
| Current Assets | $202.7M | $276.8M |
| Cash & Equivalents | $65.3M | $71.4M |
| PP&E | $13.1M | $14.3M |
| Total Liabilities | $56.2M | $93.3M |
| Current Liabilities | $26.5M | $49.8M |
| Shareholders' Equity | $196.1M | $299.8M |
| Retained Earnings | -$445.9M | -$326.2M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$132.5M | -$15.3M |
| CapEx | $2.60M | $3.52M |
| Investing Cash Flow | $125.4M | -$94.9M |
| Financing Cash Flow | $816.0K | $114.0M |
| Net Change in Cash | -$6.21M | $3.85M |
| Free Cash Flow | -$135.1M | -$18.8M |
FAQ
What is VYGR P/E and revenue?
Voyager Therapeutics Inc (VYGR) rev $40.4M.
What is VYGR revenue?
Voyager Therapeutics Inc last cached revenue is $40.4M (FY2025).
Is VYGR profitable?
Voyager Therapeutics Inc last cached net income is -$119.7M (FY2025).
What are VYGR total assets?
Voyager Therapeutics Inc last cached total assets are $252.3M (FY2025).
What is VYGR free cash flow?
Voyager Therapeutics Inc last cached free cash flow is -$135.1M (FY2025).
Not investment advice. Cached statements, not a live tape.